Wednesday 16 January 2019
Home      All news      Contact us      India
business-standard - 6 days ago

SPARC intimates of achievement of milestone - commercialisation of XELPROS

SPARC had out-licensed XELPROS to Sun Pharma in June 2015 and this commercialisation of XELPROS, has triggered a milestone payment of USD 10 Million and sales linked royalties, by Sun Pharma to SPARC.

Related news

Latest News
Hashtags:   

SPARC

 | 

intimates

 | 

achievement

 | 

milestone

 | 

commercialisation

 | 

XELPROS

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources